What is the dose of Kenalog (triamcinolone acetonide) for injection into the hand for trigger finger?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triamcinolone Acetonide Dosage for Trigger Finger Injection

For trigger finger injection in the hand, the optimal dose of triamcinolone acetonide (Kenalog) is 20 mg, which provides significantly higher clinical effectiveness compared to lower doses. 1

Evidence-Based Dosing Recommendations

The most recent and highest quality evidence from a prospective study shows clear dose-dependent effectiveness:

  • 20 mg triamcinolone acetonide: 79% effectiveness at 6 months
  • 10 mg triamcinolone acetonide: 62% effectiveness at 6 months
  • 5 mg triamcinolone acetonide: 52% effectiveness at 6 months 1

This dose-response relationship is supported by another randomized controlled trial showing that 20 mg has significantly higher success rates compared to 5 mg and 10 mg doses at 3 and 6 months post-injection 2.

Administration Technique

  1. Prepare triamcinolone acetonide 20 mg (0.5 mL of 40 mg/mL solution)
  2. Consider using without local anesthetic, as research shows adding lidocaine with epinephrine actually increases injection pain (VAS 3.5 vs 2.0) 3
  3. If dilution is needed, use sterile normal saline rather than lidocaine
  4. Inject at the A1 pulley level where the tendon enters the flexor sheath
  5. Ensure injection is into the tendon sheath, not the tendon proper

Safety Considerations

  • Avoid excessive dosing: Cases of flexor tendon rupture have been reported with 40 mg injections 4
  • Avoid repeat injections within short intervals (less than 2-3 months)
  • Diabetes management: Both steroid and NSAID injections show similar effectiveness in diabetic and non-diabetic patients 5

Follow-up Recommendations

  • Assess response at 3 weeks and 3 months post-injection
  • If inadequate response after 3 months, consider:
    • Second injection (maintaining at least 3-month interval between injections)
    • Surgical release of A1 pulley if multiple injections fail

Alternative Options

For patients who cannot receive corticosteroid injections, NSAID injections (e.g., diclofenac sodium) can be considered as they show comparable effectiveness at 3 months, though steroids provide quicker relief at 3 weeks 5.

By using the evidence-based 20 mg triamcinolone acetonide dosage, you can maximize the chances of successful treatment while minimizing the need for surgical intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.